Teva Subsidiaries Face price-fixing Allegations
Eleven Teva Subsidiaries Will Face Price-Fixing Allegations
July 25, 2017
A federal judge in Pennsylvania has ruled that 11 subsidiaries of pharmaceutical corporation Teva must face the price-fixing allegations brought against them in a suit filed by a union health insurance plan.
Pennsylvania Plumbers Local Union No. 690 Health Plan had alleged that 15 companies had artificially inflated the costs of the generic drugs they manufacture. Judge Anita Brody limited her decision to the eight subsidiaries whose actions are governed by Pennsylvania law, but ruled that the other three must still face allegations that they violated consumer protection laws of other states and territories.
Judge Brody tossed the claims of the companies that conduct no business in Pennsylvania.
Further developments in the case are expected.
If you believe you’ve been the victim of a pharmaceutical price-fixing scheme, you may have a case. Contact the expert attorneys at TheLawFirm.com to learn how we can help you.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!